Tumors hijack immune-privileging regulons via distinct cell types to confer T cell desertion and immunotherapy resistance across various cancers

Journal:

Nature Communications

Published:

2026-05-08

DOI:

10.1038/s41467-026-72538-x

Affiliations:

3

Authors:

7

Go to article

Institutions	Authors	Share
University of Pittsburgh (Pitt), United States of America (USA)	3.500000	0.50
UPMC Hillman Cancer Center (UPCI), United States of America (USA)	3.000000	0.43
UPMC Magee-Womens Hospital, United States of America (USA)	0.500000	0.07

Interested in Bioinformatics and Computational Biology?